Ocera Raises $35.5M

San Diego-based Ocera Therapeutics said today that it has raised $35.5M in a Series C funding round. The investment was led by Montagu Newhall Associates, and also included InterWest Partners, AgeChem Venture Fund, Cross Creek Capital, FinTech, and CDIB BioScience, along with prior investors Domain Associates, Sofinnova Ventures, and Thomas, McNerney & Partners. According to the firm, the round brings the company's total raised to $62M. Linda Grais of interwest joins the firm's board as part of the funding. Ocera is focused on licensing, development and commercialization of treatments for gastrointestinal and liver diseases. More information »